These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 36672914)

  • 1. SARS-CoV-2 Omicron Variant Genomic and Phylogenetic Analysis in Iraqi Kurdistan Region.
    Majed SO; Mustafa SA; Jalal PJ; Fatah MH; Miasko M; Jawhar Z; Karim AY
    Genes (Basel); 2023 Jan; 14(1):. PubMed ID: 36672914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic analysis of SARS-CoV-2 omicron sublineage BA.5.2.1 in Erbil/Iraq.
    Majed SO; Jalal PJ; Fatah MH; Karim KK; Karim AY; Miasko M; Hasannajad S; Mustafa SA
    Cell Mol Biol (Noisy-le-grand); 2023 Nov; 69(11):56-63. PubMed ID: 38015540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequencing and mutations analysis of the first recorded SARS-CoV-2 Omicron variant during the fourth wave of pandemic in Iraq.
    Ahmed JQ; Maulud SQ; Al-Qadi R; Mohamed TA; Tayib GA; Hassan AM; Taha LS; Qasim KM; Tawfeeq MA
    Braz J Infect Dis; 2022; 26(5):102677. PubMed ID: 35970304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Biological Functions and Clinical Significance of SARS-CoV-2 Variants of Corcern.
    Akkız H
    Front Med (Lausanne); 2022; 9():849217. PubMed ID: 35669924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on SARS-CoV-2 Omicron Variant of Concern and Its Peculiar Mutational Profile.
    Alkhatib M; Salpini R; Carioti L; Ambrosio FA; D'Anna S; Duca L; Costa G; Bellocchi MC; Piermatteo L; Artese A; Santoro MM; Alcaro S; Svicher V; Ceccherini-Silberstein F
    Microbiol Spectr; 2022 Apr; 10(2):e0273221. PubMed ID: 35352942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational cascade of SARS-CoV-2 leading to evolution and emergence of omicron variant.
    Bansal K; Kumar S
    Virus Res; 2022 Jul; 315():198765. PubMed ID: 35367284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and computational analysis of spike protein of newly emerged omicron variant in comparison to the delta variant of SARS-CoV-2 in Iraq.
    Rashid PMA; Salih GF
    Mol Biol Rep; 2022 Aug; 49(8):7437-7445. PubMed ID: 35698014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistence of SARS-CoV-2 infection and viral intra- and inter-host evolution in COVID-19 hospitalized patients.
    Pavia G; Quirino A; Marascio N; Veneziano C; Longhini F; Bruni A; Garofalo E; Pantanella M; Manno M; Gigliotti S; Giancotti A; Barreca GS; Branda F; Torti C; Rotundo S; Lionello R; La Gamba V; Berardelli L; Gullì SP; Trecarichi EM; Russo A; Palmieri C; De Marco C; Viglietto G; Casu M; Sanna D; Ciccozzi M; Scarpa F; Matera G
    J Med Virol; 2024 Jun; 96(6):e29708. PubMed ID: 38804179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Preliminary Genomic Analysis of the Omicron Variants of SARS-CoV-2 in Central India During the third wave of the COVID-19 Pandemic.
    Singh P; Negi SS; Bhargava A; Kolla VP; Arora RD
    Arch Med Res; 2022 Sep; 53(6):574-584. PubMed ID: 36123226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 Omicron Variant Genomic Sequences and Their Epidemiological Correlates Regarding the End of the Pandemic: In Silico Analysis.
    Kumar A; Asghar A; Singh HN; Faiq MA; Kumar S; Narayan RK; Kumar G; Dwivedi P; Sahni C; Jha RK; Kulandhasamy M; Prasoon P; Sesham K; Kant K; Pandey SN
    JMIR Bioinform Biotechnol; 2023; 4():e42700. PubMed ID: 36688013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational characterization of Omicron SARS-CoV-2 lineages circulating in Chhattisgarh, a central state of India.
    Singh P; Sharma K; Shaw D; Bhargava A; Negi SS
    Front Med (Lausanne); 2022; 9():1082846. PubMed ID: 36755883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unraveling the Dynamics of Omicron (BA.1, BA.2, and BA.5) Waves and Emergence of the Deltacton Variant: Genomic Epidemiology of the SARS-CoV-2 Epidemic in Cyprus (Oct 2021-Oct 2022).
    Chrysostomou AC; Vrancken B; Haralambous C; Alexandrou M; Gregoriou I; Ioannides M; Ioannou C; Kalakouta O; Karagiannis C; Marcou M; Masia C; Mendris M; Papastergiou P; Patsalis PC; Pieridou D; Shammas C; Stylianou DC; Zinieri B; Lemey P; The Comessar Network ; Kostrikis LG
    Viruses; 2023 Sep; 15(9):. PubMed ID: 37766339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants.
    Zhang J; Han ZB; Liang Y; Zhang XF; Jin YQ; Du LF; Shao S; Wang H; Hou JW; Xu K; Lei W; Lei ZH; Liu ZM; Zhang J; Hou YN; Liu N; Shen FJ; Wu JJ; Zheng X; Li XY; Li X; Huang WJ; Wu GZ; Su JG; Li QM
    Elife; 2022 Aug; 11():. PubMed ID: 36004719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of SARS-Cov-2 omicron variant with the previously identified SARS-Cov-2 variants in Egypt, 2020-2022: insight into SARS-Cov-2 genome evolution and its impact on epidemiology, clinical picture, disease severity, and mortality.
    Kandeel A; Moatasim Y; Fahim M; Bahaaeldin H; El-Shesheny R; Roshdy WH; Kamel MN; Shawky S; Gomaa M; Naguib A; Guindy NE; Deghedy O; Kamel R; Khalifa M; Galal R; Hassany M; Mahmoud G; Kandeil A; Afifi S; Mohsen A; Fattah MA; Kayali G; Ali MA; Abdelghaffar K
    BMC Infect Dis; 2023 Aug; 23(1):542. PubMed ID: 37596534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phylogenetic, Sequencing, and Mutation Analysis of SARS-CoV-2 Omicron (BA.1) and Its Subvariants (BA.1.1, BA.2) During the Fifth Wave of the COVID-19 Pandemic in the Iraqi Kurdistan Region.
    Taher SM; Abdo JM; Merza MA
    Cureus; 2023 Nov; 15(11):e48637. PubMed ID: 38090439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of SARS CoV-2 Omicron BA.1 and a novel Delta lineage by rapid methods and partial spike protein sequences in Sulaymaniyah Province, Iraq.
    Rasheed MK; Awrahman HA; Amin Al-Jaf SM; Niranji SS
    Immun Inflamm Dis; 2023 Mar; 11(3):e801. PubMed ID: 36988244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epistasis at the SARS-CoV-2 Receptor-Binding Domain Interface and the Propitiously Boring Implications for Vaccine Escape.
    Rochman ND; Faure G; Wolf YI; Freddolino PL; Zhang F; Koonin EV
    mBio; 2022 Apr; 13(2):e0013522. PubMed ID: 35289643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omicron and Delta variant of SARS-CoV-2: A comparative computational study of spike protein.
    Kumar S; Thambiraja TS; Karuppanan K; Subramaniam G
    J Med Virol; 2022 Apr; 94(4):1641-1649. PubMed ID: 34914115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 in relation to global vaccination and booster doses: what is the future of vaccination in the battle against COVID-19?
    Khalid N; Wheeler AM
    Bratisl Lek Listy; 2022; 123(9):631-633. PubMed ID: 36039880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the novel SARS-CoV-2 Omicron (B.1.1.529) variant of concern and its global perspective.
    Saxena SK; Kumar S; Ansari S; Paweska JT; Maurya VK; Tripathi AK; Abdel-Moneim AS
    J Med Virol; 2022 Apr; 94(4):1738-1744. PubMed ID: 34905235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.